Other Less Prevalent Tumors of the Central Nervous System

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2023 Jul 15

PMID 37452956

Authors

Jody Filippo Capitanio

Pietro Mortini

Affiliations

Soon will be listed here.

Abstract

The presented tumors in this chapter are somewhat very rare, and their management is still debated due to the scarcity of information about their cell of origin, behavior, and biology. Treatment options are still limited, but we are confident that in the near future by discovering the genetic and biological mechanisms that drive tumor growth we will be able to offer new target therapies that should be flanked by surgery, radiotherapy, and chemotherapeutic agents actually in use. The purpose of this chapter is to highlight the most important known characteristics of these tumors offering the chance to recognize the disease and then offer the best opportunity for treatment to patients. The 5th WHO Classification Central Nervous System features substantial changes by moving further to advance the role of molecular diagnostics in CNS tumor classification, but remaining rooted in other established approaches to tumor characterization, including histology and immunohistochemistry, and probably, the category of many tumors will change. Here, the most important characteristics of each neoplasm are summarized focusing on genetic mechanisms and molecular pathways, their histopathologic footprints, signs and symptoms, radiologic features, therapeutic approaches, and prognosis as well as follow-up protocols. Schematic classifications are also presented to offer a better understanding of the pathology.

References

Abdulkader M, Mansour N, Van Gompel J, Bosh G, Dropcho E, Bonnin J . Disseminated choroid plexus papillomas in adults: A case series and review of the literature. J Clin Neurosci. 2016; 32:148-54. DOI: 10.1016/j.jocn.2016.04.002. View

Abel T, Baker S, Fraser M, Tihan T, Nelson J, Yachnis A . Lhermitte-Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol. 2005; 64(4):341-9. DOI: 10.1093/jnen/64.4.341. View

Adachi J, Nishikawa R, Hirose T, Matsutani M . Mixed neuronal-glial tumor of the fourth ventricle and successful treatment of postoperative mutism with bromocriptine: case report. Surg Neurol. 2005; 63(4):375-9. DOI: 10.1016/j.surneu.2004.05.039. View

Ayala-Ramirez M, Feng L, Johnson M, Ejaz S, Habra M, Rich T . Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2010; 96(3):717-25. DOI: 10.1210/jc.2010-1946. View

Badalian-Very G, Vergilio J, Degar B, Macconaill L, Brandner B, Calicchio M . Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010; 116(11):1919-23. PMC: 3173987. DOI: 10.1182/blood-2010-04-279083. View

Baek W, Lachkar S, Iwanaga J, Oskouian R, Loukas M, Oakes W . Comprehensive Review of Spinal Neurenteric Cysts with a Focus on Histopathological Findings. Cureus. 2018; 10(9):e3379. PMC: 6263491. DOI: 10.7759/cureus.3379. View

Bianchi F, Tamburrini G, Massimi L, Caldarelli M . Supratentorial tumors typical of the infantile age: desmoplastic infantile ganglioglioma (DIG) and astrocytoma (DIA). A review. Childs Nerv Syst. 2016; 32(10):1833-8. DOI: 10.1007/s00381-016-3149-4. View

Bidinotto L, Scapulatempo-Neto C, Mackay A, de Almeida G, Scheithauer B, Berardinelli G . Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal Cord. PLoS One. 2015; 10(9):e0137690. PMC: 4570813. DOI: 10.1371/journal.pone.0137690. View

Blumcke I, Wiestler O . Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002; 61(7):575-84. DOI: 10.1093/jnen/61.7.575. View

10.

Braoudaki M, Lambrou G, Papadodima S, Stefanaki K, Prodromou N, Kanavakis E . MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors. Med Oncol. 2015; 33(1):5. DOI: 10.1007/s12032-015-0719-3. View

11.

Browne J, Fisch U, Valavanis A . Surgical therapy of glomus vagale tumors. Skull Base Surg. 1993; 3(4):182-92. PMC: 1656457. DOI: 10.1055/s-2008-1060583. View

12.

Buffet A, Venisse A, Nau V, Roncellin I, Boccio V, Le Pottier N . A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma. Horm Metab Res. 2012; 44(5):359-66. DOI: 10.1055/s-0032-1304594. View

13.

Burnichon N, Cascon A, Schiavi F, Morales N, Comino-Mendez I, Abermil N . MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma. Clin Cancer Res. 2012; 18(10):2828-37. DOI: 10.1158/1078-0432.CCR-12-0160. View

14.

Carneiro S, Scheithauer B, Nascimento A, Hirose T, Davis D . Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study. Am J Clin Pathol. 1996; 106(2):217-24. DOI: 10.1093/ajcp/106.2.217. View

15.

Cerisano V, Aalto Y, Perdichizzi S, Bernard G, Manara M, Benini S . Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. Oncogene. 2004; 23(33):5664-74. DOI: 10.1038/sj.onc.1207741. View

16.

Chappe C, Padovani L, Scavarda D, Forest F, Nanni-Metellus I, Loundou A . Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression. Brain Pathol. 2013; 23(5):574-83. PMC: 8029244. DOI: 10.1111/bpa.12048. View

17.

Chen Y, Wong T, Ho D, Huang P, Chang K, Shiau C . Impact of radiotherapy for pediatric CNS atypical teratoid/rhabdoid tumor (single institute experience). Int J Radiat Oncol Biol Phys. 2006; 64(4):1038-43. DOI: 10.1016/j.ijrobp.2005.10.001. View

18.

Chmielecki J, Crago A, Rosenberg M, OConnor R, Walker S, Ambrogio L . Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013; 45(2):131-2. PMC: 3984043. DOI: 10.1038/ng.2522. View

19.

Courtillot C, Laugier Robiolle S, Cohen Aubart F, Leban M, Renard-Penna R, Drier A . Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester Disease. J Clin Endocrinol Metab. 2015; 101(1):305-13. DOI: 10.1210/jc.2015-3357. View

20.

Czapiewski P, Kunc M, Gorczynski A, Haybaeck J, Okon K, Reszec J . Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature. Hum Pathol. 2018; 79:144-150. DOI: 10.1016/j.humpath.2018.05.013. View